## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that
Expression of epidermal growth factor receptor (EGFr) immunoreactivity in human cutaneous nerves and sensory corpuscles
โ Scribed by Vega, J. A. ;Vazquez, E. ;Naves, F. J. ;Calzada, B. ;Del Valle, M. E. ;Represa, J. J.
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 998 KB
- Volume
- 240
- Category
- Article
- ISSN
- 0003-276X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: The medial wall of the vomeronasal organ (VNO) is lined with a sensory epithelium that is closely related to the olfactory epithelium, which is developed from the olfactory placode. It undergoes continuous replacement during its life span. In other sensory epithelia, cell proliferat
## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressaยฎ (ZD1839) is an orally active, selective EGFRโTKI (epidermal growth factor receptorโtyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell
High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant